Literature DB >> 25620700

A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.

Mar Matarin1, Dervis A Salih2, Marina Yasvoina2, Damian M Cummings2, Sebastian Guelfi3, Wenfei Liu2, Muzammil A Nahaboo Solim4, Thomas G Moens2, Rocio Moreno Paublete2, Shabinah S Ali2, Marina Perona5, Roshni Desai6, Kenneth J Smith6, Judy Latcham7, Michael Fulleylove7, Jill C Richardson8, John Hardy9, Frances A Edwards10.   

Abstract

We provide microarray data comparing genome-wide differential expression and pathology throughout life in four lines of "amyloid" transgenic mice (mutant human APP, PSEN1, or APP/PSEN1) and "TAU" transgenic mice (mutant human MAPT gene). Microarray data were validated by qPCR and by comparison to human studies, including genome-wide association study (GWAS) hits. Immune gene expression correlated tightly with plaques whereas synaptic genes correlated negatively with neurofibrillary tangles. Network analysis of immune gene modules revealed six hub genes in hippocampus of amyloid mice, four in common with cortex. The hippocampal network in TAU mice was similar except that Trem2 had hub status only in amyloid mice. The cortical network of TAU mice was entirely different with more hub genes and few in common with the other networks, suggesting reasons for specificity of cortical dysfunction in FTDP17. This Resource opens up many areas for investigation. All data are available and searchable at http://www.mouseac.org.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25620700     DOI: 10.1016/j.celrep.2014.12.041

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  98 in total

Review 1.  Immunological signatures in frontotemporal lobar degeneration.

Authors:  Daniel W Sirkis; Luke W Bonham; Celeste M Karch; Jennifer S Yokoyama
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

Review 2.  NMNAT: It's an NAD+ synthase… It's a chaperone… It's a neuroprotector.

Authors:  Jennifer M Brazill; Chong Li; Yi Zhu; R Grace Zhai
Journal:  Curr Opin Genet Dev       Date:  2017-04-23       Impact factor: 5.578

Review 3.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

Review 4.  Neuroinflammatory responses in Alzheimer's disease.

Authors:  Cira Dansokho; Michael Thomas Heneka
Journal:  J Neural Transm (Vienna)       Date:  2017-12-22       Impact factor: 3.575

Review 5.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

6.  Susceptibility of brain atrophy to TRIB3 in Alzheimer's disease, evidence from functional prioritization in imaging genetics.

Authors:  Marco Lorenzi; Andre Altmann; Boris Gutman; Selina Wray; Charles Arber; Derrek P Hibar; Neda Jahanshad; Jonathan M Schott; Daniel C Alexander; Paul M Thompson; Sebastien Ourselin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-06       Impact factor: 11.205

7.  Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models.

Authors:  C Y Daniel Lee; Anthony Daggett; Xiaofeng Gu; Lu-Lin Jiang; Peter Langfelder; Xiaoguang Li; Nan Wang; Yingjun Zhao; Chang Sin Park; Yonatan Cooper; Isabella Ferando; Istvan Mody; Giovanni Coppola; Huaxi Xu; X William Yang
Journal:  Neuron       Date:  2018-03-07       Impact factor: 17.173

8.  Polygenic risk score analysis of pathologically confirmed Alzheimer disease.

Authors:  Valentina Escott-Price; Amanda J Myers; Matt Huentelman; John Hardy
Journal:  Ann Neurol       Date:  2017-08-09       Impact factor: 10.422

9.  CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.

Authors:  Boris-Stephan Rauchmann; Thomas Schneider-Axmann; Panagiotis Alexopoulos; Robert Perneczky
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

10.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy.

Authors:  Peng Yuan; Carlo Condello; C Dirk Keene; Yaming Wang; Thomas D Bird; Steven M Paul; Wenjie Luo; Marco Colonna; David Baddeley; Jaime Grutzendler
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.